EPISODE 30 - Caring for people receiving belantamab mafodotin (Blenrep) in multiple myeloma: a practical nursing guide

Belantamab mafodotin is now TGA-registered for people with multiple myeloma who have had at least one prior line of therapy. Available exclusively to CNSA members, we encourage you to login and listen today!